Perspective Therapeutics
CATX
30 hedge funds and large institutions have $1.74M invested in Perspective Therapeutics in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
3% more funds holding
Funds holding: 29 → 30 (+1)
0.01% more ownership
Funds ownership: 0.86% → 0.87% (+0.01%)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
42% less capital invested
Capital invested by funds: $2.99M → $1.74M (-$1.24M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$141K |
| 2 |
HPWM
Highland Private Wealth Management
Bellevue,
Washington
|
+$55.7K |
| 3 |
VF
Virtu Financial
New York
|
+$12.1K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$9.9K |
| 5 |
SIA
Starfire Investment Advisers
Southfield,
Michigan
|
+$8.56K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$187K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$5K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$4.2K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
-$3K |
CATX Hedge Fund Activity: Q4 2018 in Review
30 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q4 2018, worth a combined $1.74M — down 42% from $2.99M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CATX positions and 4 closed out — a net gain of 1 holder — while 4 added to existing stakes and 4 trimmed.
The largest buyer was Sabby Management, adding an estimated $141K. The largest seller was Vanguard Group, cutting an estimated $187K.
- 30 institutional investors held Perspective Therapeutics (CATX) as of Q4 2018, up from 29 in Q3 2018.
- Funds reported $1.74M of Perspective Therapeutics stock for Q4 2018, down 42% quarter-over-quarter.
- 5 funds opened new Perspective Therapeutics positions in Q4 2018 and 4 closed out, a net change of +1 holder.
- The largest Perspective Therapeutics buyer in Q4 2018 was Sabby Management, an estimated $141K added.
- The largest Perspective Therapeutics seller in Q4 2018 was Vanguard Group, an estimated $187K sold.
Based on aggregated 13F filings for Q4 2018.